Events & conferences in the Life Sciences industry

Novotel London West
London UK

Europe’s Leading Biopartnering and Investment Conference Approaching the 12th consecutive year, our goal for BioTrinity is simple – to create an ideal network and partnering platform for the global life sciences industry under one roof, ultimately to help shape our healthcare future. Our theme for BioTrinity 2018 is 'Next Generation Healthcare' which we will explore via a range of insightful keynote and panel discussions including 'AI and Drug Discovery', 'An insight into Nanotechnology', 'Next Generation Chemistry' and 'Fintech and the Future of the Investment Industry' - keep an eye on the conference programme. BioTrinity offers unique access to investors, big pharma executives and innovative CEO's of emerging R&D companies seeking to strike deals and grow their networks. BioTrinity is developed and organised by OBN, the not-for-profit Membership organisation supporting and bringing together the life sciences industry, their corporate partners and investors.

Amsterdam RAI Convention Center
Amsterdam The Netherlands

Bringing together 900+ attendees from all major departments in bioprocessing: Cell Culture, Downstream, Manufacturing, Vaccines, Viral Safety and Cell Line Development this April in Amsterdam, Europe’s largest bioprocessing event BPI Europe 2018 will provide you with the latest advice on how optimise bioprocessing through connecting science, technology and business.

Amsterdam RAI Convention Center
Amsterdam The Netherlands

Viral Safety and Raw Materials 2018 event will be held 23-25 April 2018 in the RAI Amsterdam – joining the largest Bioprocessing event in Europe – BPI Europe. With 900+ attendees, 275+ companies and over 70 sessions showcasing new data and technologies, including new focussed sessions on Continuous Processing, Viral Safety for ATMPs, NGS, Novel Clearance, Inactivation with Novel Detergents and much more, this year is one not to be missed!

Amsterdam RAI Convention Center
Amsterdam The Netherlands

Cell Line Development & Engineering 2018 event will be held 23-25 April 2018 in the RAI Amsterdam – joining the largest Bioprocessing event in Europe – BPI Europe. With 900+ attendees, 275+ companies and over 70 sessions showcasing new data and technologies, this year is one not to be missed! Premier industry-led cell line development and engineering event – 3 days dedicated to cutting edge science, technologies and strategies: Day One: Monoclonality & Complex Molecules Day Two: Cell Line & Host Cell Engineering Day Three: Automation & Manufacturability Assessment

Amsterdam RAI Convention Center
Amsterdam The Netherlands

Changing the shape of vaccine development, manufacturing and delivery Vaccine Manufacturing 2018 event will be held 23-25 April 2018 in the RAI Amsterdam – joining the largest Bioprocessing event in Europe – BPI Europe. With 900+ attendees, 275+ companies and 4 days of in-depth programmes in specific fields, this year is one not to be missed! Don't miss this opportunity to achieve success in vaccine manufacturing by benchmarking with leading industry personalities.

Göteborg Sweden

Vitalis is the largest eHealth event in Scandinavia. This year, the conference will be co-located with the 29th Medical Informatics Europe conference, MIE 2018, thus closing the gap between an international audience of academics, health professionals and industry partners. The conferences are expected to draw together over 5 500 attendees during three days of high-level networking, knowledge building and important discussions on the future of healthcare. Visitors are from municipalities and county councils as well as from authorities, patient organisations and the private sector. Enterprise Europe Network in collaboration with Business Region Göteborg, Scanbalt and HealthTech Nordic invites you to join a high-profile B2B matchmaking event (complimentary with a Vitalis/MIE2018 conference registration). The matchmaking will offer healthcare technology executives and key opinion leaders from Europe as well as disruptive and promising companies from Scandinavia and the Baltic region the possibility to meet bilaterally in pre-arranged 20 minutes meetings.

London United Kingdom

Learn and practice in role plays the whole armamentarium of winning strategies, tools, dos & don’ts, tricks & tips in each step of the pharma licensing negotiation process: planning – internal negotiations – making the first contact – term sheet assumptions – face-to-face meetings – resolving issues – contract closure.

Shanghai China

LINGMED LIMITED SHANGHAI together with Venture Valuation is pleased to invite you to a full-day workshop on pharma – biotech Product and Company Valuation. Understand the valuation concepts and techniques that are commonly applied in the pharma and biotech world. Know how to assess and calculate the value of a biotech company. Learn how to calculate the value of a pharmaceutical in development and how to structure a licensing deal.

Kempinski Hotel
Suzhou China

Access a world of opportunities through life science partnering in China. ChinaBio® Partnering Forum is the premier life science partnering event in China. The conference will be held April 25–26 in Suzhou, attracting biotech and pharma leaders from around the world along with hundreds of China-based developers of novel technologies for two days of productive partnering. For the event’s tenth anniversary, we expect over 900 delegates from more than 460 companies and at least 22 countries to attend, making it the largest partnering conference in China. The 2018 edition promises attendance from pharma and biotech companies as well as leading researchers from China's top universities and institutes. The conference also features partneringONE®, the gold standard partnering platform enabling delegates to efficiently identify, meet and network with companies from across the life science value chain.

Amsterdam RAI Convention Center
Amsterdam The Netherlands

Changing the shape of vaccine development, manufacturing and delivery: Vaccine Manufacturing 2018 event will be held 23-25 April 2018 in the RAI Amsterdam – joining the largest Bioprocessing event in Europe – BPI Europe. With 900+ attendees, 275+ companies and 4 days of in-depth programmes in specific fields, this year is one not to be missed! Don't miss this opportunity to achieve success in vaccine manufacturing by benchmarking with leading industry personalities.

London United Kingdom

Be able to decide on the best deal type – Know what to include in CDAs, MTAs and term sheets – Learn how to prepare product information and how to find potential partners – Know how to calculate the value of your product and optimise the deal structure.

Marriott Wardman Park
Washington USA

The 15th Annual World Health Care Congress offers industry-specific content in a multi-track format designed to deliver practical takeaways to improve your business and inform strategy. Bring your team this April to maximize learning and networking. Network with life sciences, government, technology, and other organizations dedicated to achieving more affordable care and better outcomes.

Renaissance Waterfront Hotel
Boston USA

Now in its 13th year, the Neurotech Investing & Partnering Conference is the premier business and investment conference for commercial neuroscience including pharmaceuticals, medical devices, diagnostics and neurosoftware. The conference features keynotes, investor panels, cutting edge company presentations, and panel discussions on a comprehensive selection of neurotech topics. Our goal is to provide a highly-interactive environment where cutting edge technologies, devices, drugs and therapies inspire new collaborations and secure financing to navigate the development path and ultimately reach patients. Organized by the Neurotechnology Industry Organization and Cambridge Innovation Institute, the 13th annual conference will be held May 1-2, 2018 at the Renaissance Waterfront Hotel in Boston, MA. The Neurotech Investing and Partnering Conference is a global forum where investors, executives, entrepreneurs, scientists and others involved in the development of new treatments and diagnostics for the brain and nervous system come together to shape the future of their organization and the industry. This market-defining conference features keynotes on the state of the neurotech industry, cutting edge company presentations, leading translational research projects and panel discussions on a comprehensive selection of neurotech topics.

Hilton Toronto Airport Hotel
Toronto Canada

Opportunities out of Obstacles: Overcoming Barriers in Clinical Trials - Learn solutions you can implement for your clinical studies today. - Numerous opportunities to meet, connect and engage with various decision-makers and stakeholders.

Seaport World Trade Center
Boston USA

Since its debut in 2002, the annual Bio-IT World Conference & Expo has established itself as a premier event showcasing the myriad IT and informatics applications and enabling technologies that drive biomedical research, drug discovery & development, and clinical and healthcare initiatives. The Bio-IT World Conference & Expo continues to be a vibrant event that unites 3,400+ life sciences, pharmaceutical, clinical, healthcare, and IT professionals from more than 35 countries. Spanning three days, the 2018 meeting includes 16 parallel conference tracks and 14 pre-conference workshops. Compelling talks, including best practice case studies and joint partner presentations, will feature over 280 of your fellow industry and academic colleagues discussing themes of big data, smart data, cloud computing, trends in IT infrastructure, omics technologies, high-performance computing, data analytics, open source and precision medicine, from the research realm to the clinical arena.

De Vere Grand Connaught Rooms
London United Kingdom

The 2018 Biotech Investment showcase is the UK and Europe’s most focussed and leading-edge funding, investment and partnering forum in the biotech sector, hosting over 300 attendees. Leading VC funds, investors, hedge funds, emerging successful biotech spinoffs, early stage biotech discovery and clinical companies and KOLs in the sector will be attending this one of a kind showcase event on the 22nd & 23rd May 2018 in London. The event will help to identify key technological and scientific investment areas and offers a unique networking, partnering and business development opportunity for those involved. At the showcase event, there are two dedicated sessions on the agenda for start-up entrepreneurs or scientists to present new products and research in front of leading pharma/biotech venture companies, VCs and Technology Transfer offices.

Hilton San Diego Resort and Spa
San Diego USA

World Biosimilar Congress USA has become a staple meeting where biosimilar stakeholders gather to address the current and future state of Biosimilars in the United States. The 2018 installation of this meeting will allow us to continue to dive deeper into both the science of Biosimilar development – and the business needs for companies that continue to seek FDA approval. The growth from 2017 allows us to promise an even more robust crowd of key stakeholders in 2018.

Hyatt Centric Chicago Magnificent Mile Hotel
Chicago USA

Taking place on the first day of ASCO, the 4th Annual Immuno-Oncology: BD&L and Investment Forum is designed to bring together thought leaders from cancer research institutes, patient advocacy groups, pharma and biotech to facilitate partnering, funding and investment. We expect around 250 delegates and about 30 presentations by listed and private biotechnology companies seeking licensing & investment. Numerous networking opportunities available via an online one-to-one meeting system with dedicated meeting facilities to make the event more transactional.

Boston Convention & Exhibition Center
Boston USA

BIO International Convention is back in Boston, June 4-7, to celebrate history-making innovation. Join the global biotech community to discover the next generation of cutting-edge products, therapies, and cures…and how we are making history every day. • Join 16,000 Global Business Development Leaders from 5,000 Companies • Be a Part of 41,000+ BIO One-on-One Partnering™ Meetings in just 3.5 Days • Attend 18+ Session Tracks, 250 Company Presentations and Start-Up Pitches • Network with 1,800+ Exhibitors, Specialty Pavilions and Zones—plus top CRO’s and CMO’s Learn more about BIO 2018 now at:

The Westin Copley Place
Bost USA

The 17th Annual World Preclinical Congress focuses on the latest trends and technologies impacting drug discovery and translational research. The Congress offers a unique opportunity for chemists, biologists, pharmacologists, cancer researchers, neuroscience scientists, toxicologists, bioengineers, screening experts and translational scientists in industry and academia as well as technology providers to come together and exchange expertise and opinions. World Preclinical Congress is a key networking event yielding new partnerships that accelerate preclinical research and translation across all therapeutic areas.

Congress Centre Basel
Basel Switzerland

Biotech Outsourcing Strategies 2018 is a leading R&D outsourcing-partnering event. The expanded scope in 2018 will include Discovery Outsourcing in addition to CMC Outsourcing for both small molecules and biologics. Established in 2006 the event formula includes 4 key components: Presentations from thoughts leaders in the industry; 1-to-1 Partnering facilitated by our partnering software: Exhibition featuring leading international CROs and CMOs: Informal networking in a friendly, open atmosphere which encourages the forging of new business relationships. For outsourcing stakeholders, contract givers and contract acceptors, BOS is a must attend event. We hope to welcome you to Basel.

Hynes Convention Center
Boston USA

BioPharm America™ is a unique partnering event that forms the nexus of discovery and realization. Startup companies, established biotech and entrepreneurs from academia attend in search of finance, pharma and development partners. The event format highlights innovation and promotes new business relationships by bringing dealmakers from the life science ecosystem together to engage and de-risk the enormous task of drug development. Life science executives from around the world gather to identify, meet and to enter into strategic relationships facilitated by partneringONE®, the world’s leading web-based partnering system. BioPharm America is the only event in North America based on the same reputable formula as EBD Group’s acclaimed European events BIO-Europe® and BIO-Europe Spring®. In 2017, BioPharm America attracted 800+ delegates from over 500 companies who participated in 2,300+ scheduled one-to-one meetings. BioPharm America is now part of Biotech Week Boston, and together they draw a total of over 4,500 life science leaders, scientists and innovators.

Brussels Belgium

Understand the structure of the pharma business development process – Grasp the terminology, challenges, concepts & tools in each step, from analysis and planning... up to closing and following-up a deal – Be prepared for the financial and legal pitfalls.

Congress Centre Basel
Basel Switzerland

The programme is designed to highlight the latest industry developments and showcase emerging and innovative technology companies seeking finance and partnerships. The delegates are comprised of Healthcare, MedTech, Healthcare IT, and Digital Health companies as well as consultants, bankers and corporate & financial investors. We expect over 250 delegates and 25 presenting companies. The Meeting will provide a number of networking opportunities via our online 1-2-1 meeting system which allows you to pre-book meetings with all the attendees at the dedicated meeting facilities.

Congress Centre Basel
Basel Switzerland

The forum is recognised as the leading international stage for those interested in investing and partnering in the biotech and life science industry and is highly transactional. The Forum draws together an exciting cross-section of early-stage/pre-IPO, late-stage and public companies with leading investors, analysts, money managers and pharma licensing executives. Supported and designed by leading figures within Europe’s bio industry, this event will once again be covered by our regular media partners. We expect over 600 delegates and 100 presenting companies.

Madrid Spain

Understand the valuation concepts and techniques that are commonly applied in the pharma and biotech world – Know how to assess and calculate the value of a biotech company – Learn how to calculate the value of a pharmaceutical in development and how to structure a licensing deal.

Westin St. Francis Hotel
San Francisco USA

The BIO Investor Forum is an international biotech investor conference focused on early and established private companies as well as emerging public companies. The event features plenary sessions, business roundtables and therapeutic workshops, company presentations, and One-on-One Partnering™ meetings.

Zurich Switzerland

Understand the valuation concepts and techniques that are commonly applied in the pharma and biotech world – Know how to assess and calculate the value of a biotech company – Learn how to calculate the value of a pharmaceutical in development and how to structure a licensing deal.

Brussels Belgium

Be able to decide on the best deal type for products in R&D – Know what to include in CDAs, MTAs and term sheets – Learn how to prepare product information and how to find potential partners – Know how to calculate the value of your product and optimise the deal structure.

Brussels Belgium

Learn and practice in role plays the whole armamentarium of winning strategies, tools, dos & don’ts, tricks & tips in each step of the pharma licensing negotiation process: planning – internal negotiations – making the first contact – term sheet assumptions – face-to-face meetings – resolving issues – contract closure.

London United Kingdom

Understand the structure of the pharma business development process – Grasp the terminology, challenges, concepts & tools in each step, from analysis and planning... up to closing and following-up a deal – Be prepared for the financial and legal pitfalls.